Objective To investigate the changes and clinical significance of serum soluble intercellular ad-hesion molecule-1(sICAM-1),vascular endothelial growth factor(VEGF)and soluble across a membrane protein(sFas)in acute leukemia.Methods A total of patients with acute leukemia admitted to the People's Hospital of Anyue County from May 2020 to May 2022 were selected as the observation group,and 65 healthy people who underwent physical examination in the hospital during the same period were selected as the control group.All patients were treated with chemotherapy after admission,and followed up by telephone and outpa-tient for 1 year.The levels of serum sICAM-1,VEGF and sFas were compared between the two groups,and the levels of serum sICAM-1,VEGF and sFas were compared between the patients with different efficacy and different prognosis.The receiver operating characteristic(ROC)curve was established to evaluate the predic-tive value of related indicators for the efficacy and prognosis of acute leukemia.Results Compared with con-trol group,the levels of serum sICAM 1,VEGF,sFas in the observation group were increased(P＜0.05).Compared with the non-complete remission(CR)patients,the serum VEGF level in CR patients was signifi-cantly increased(P＜0.05).Compared with the good prognosis patients,the levels of serum sICAM-1,VEGF and sFas in the poor prognosis patients were increased(P＜0.05).ROC curve analysis showed that the area under the curve(AUC)of VEGF in evaluating the efficacy of acute leukemia was 0.778.The AUC for evalua-ting the prognosis of acute leukemia with sICAM-1,VEGF,and sFas alone and in combination were 0.793,0.729,0.666,and 0.889,respectively.Conclusion The levels of serum sICAM-1,VEGF and sFas are in-creased in patients with acute leukemia.The combination of sICAM-1,VEGF and sFas has certain clinical ref-erence value in evaluating the efficacy and prognosis of acute leukemia.